Placebo-controlled trial of glycine added to clozapine in schizophrenia

American Journal of Psychiatry

Volumn 157, Issue 5, 2000, Pages 826-828

  Evins, A Eden ^a   Fitzgerald, Sandra M ^b   Wine, Lara ^b   Rosselli, Roseanne ^b   Goff, Donald C ^b  

^a Freedom Trail Clinic   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; CYCLOSERINE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; CLOZAPINE; COGNITION DISORDERS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLYCINE; HUMANS; MALE; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0034058017     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.5.826     Document Type: Article

References (11)

1. Goff DC, Tsai G, Manoach DS, Flood J, Darby DG, Coyle JT: D-Cycloserine added to clozapine for patients with schizophrenia. Am J Psychiatry 1996; 153:1628-1630
2. Evins AE, Amico ET, Shih V, Goff DC: Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics. J Neural Transm 1997; 104:761-766
3. Goff DC, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld DA, Hayden DL, McCarley R, Coyle JT: A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry 1999; 56:21-27
4. Goff DC, Henderson DC, Evins AE, Amico E: A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia. Biol Psychiatry 1999; 45:512-514
5. Emmett M, Mick S, Cler J: Actions of D-cycloserine at the N-methyl-D-aspartate-assodated glycine receptor site in vivo. Neuropharmacology 1991; 30:1167-1171
6. Nilsson M, Carlsson A, Carlsson ML: Glycine and D-serine decrease MK-801-induced hyperactivity in mice. J Neural Transm 1997; 104:1195-1205
7. Javitt DC, Balla A, Sershen H, Lajtha A: Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors. Biol Psychiatry 1999; 45:668-679
8. Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M: Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry 1999; 56:29-36
9. Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer J-P: Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 1994; 151:1234-1236
10. Tsai G, Yang P, Chung LC, Lange N, Coyle JT: D-Serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 1998; 44:1081-1089
11. Potkin SG, Jin Y, Bunney BG, Costa J, Gulasekaram B: Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia. Am J Psychiatry 1999; 156:145-147